Shares of AbbVie and Johnson & Johnson took a hit Friday after FDA briefing documents hinted a cheaper competitor for the drug companies’ blockbuster anti-inflammatory treatments could be headed to market soon.
from WSJ.com: US Business http://ift.tt/1Rb283P
via IFTTT
No comments:
Post a Comment